$1.48
1.37% day before yesterday
Nasdaq, Dec 27, 10:00 pm CET
ISIN
US09075X1081
Symbol
BDSX

Biodesix Inc Stock price

$1.48
+0.06 3.86% 1M
-0.02 1.33% 6M
-0.36 19.57% YTD
-0.34 18.68% 1Y
-2.90 66.21% 3Y
-11.33 88.45% 5Y
-11.33 88.45% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
+0.02 1.37%
ISIN
US09075X1081
Symbol
BDSX
Sector

Key metrics

Market capitalization $215.29m
Enterprise Value $245.74m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 3.75
P/S ratio (TTM) P/S ratio 3.28
P/B ratio (TTM) P/B ratio 7.73
Revenue growth (TTM) Revenue growth 48.91%
Revenue (TTM) Revenue $65.56m
EBIT (operating result TTM) EBIT $-34.56m
Free Cash Flow (TTM) Free Cash Flow $-61.42m
Cash position $31.51m
EPS (TTM) EPS $-0.39
P/E forward negative
P/S forward 3.04
EV/Sales forward 3.47
Short interest 0.68%
Show more

Is Biodesix Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Biodesix Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Biodesix Inc forecast:

6x Buy
100%

Analyst Opinions

6 Analysts have issued a Biodesix Inc forecast:

Buy
100%

Financial data from Biodesix Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
66 66
49% 49%
100%
- Direct Costs 15 15
13% 13%
22%
51 51
64% 64%
78%
- Selling and Administrative Expenses 71 71
12% 12%
108%
- Research and Development Expense 9.03 9.03
23% 23%
14%
-29 -29
34% 34%
-45%
- Depreciation and Amortization 5.36 5.36
24% 24%
8%
EBIT (Operating Income) EBIT -35 -35
29% 29%
-53%
Net Profit -44 -44
31% 31%
-67%

In millions USD.

Don't miss a Thing! We will send you all news about Biodesix Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Biodesix Inc Stock News

Neutral
Seeking Alpha
about 2 months ago
Biodesix, Inc. (NASDAQ:BDSX ) Q3 2024 Earnings Conference Call November 1, 2024 8:30 AM ET Company Participants Chris Brinzey - Investor Relations Scott Hutton - Chief Executive Officer Robin Harper Cowie - Chief Financial Officer Conference Call Participants Andrew Brackmann - William Blair Kyle Mikson - Canaccord Genuity Dan Brennan - TD Cowen Sung Ji Nam - Scotia Bank Bill Bonello - Craig-Ha...
Neutral
GlobeNewsWire
about 2 months ago
Q3 2024 revenue grew 35% over Q3 2023 to $18.2 million; Q3 2024 gross profit margin of 77.0%, up from 76.1% in Q3 2023; Q3 2024 Net loss improved by 6% compared to Q3 2023; Conference Call and Webcast Today at 8:30 a.m. ET LOUISVILLE, Colo.
Neutral
GlobeNewsWire
2 months ago
LOUISVILLE, Colo., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer, and Robin Cowie, Chief Financial Officer, will participate in three upcoming investor conferences:
More Biodesix Inc News

Company Profile

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. It offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer; and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It is a data-driven diagnostic solutions company with proprietary AI platform to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus in lung disease. The firm offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. . The company was founded in 2005 and is headquartered in Boulder, CO.

Head office United States
CEO Scott Hutton
Employees 217
Founded 2005
Website www.biodesix.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today